Computer-Mediated Communication Systems: Status and Evaluation synthesizes current knowledge about computerized conferencing systems, electronic mail, and office information-communication systems. It should be of interest both to students and researchers studying this new form of electronic communication and to organizations that are planning the installation of electronic mail or other computer-mediated communication systems and that need to be aware of the information gleaned from the studies presented here. The book is organized into four main sections, focusing on the following issues: (1) What are the important considerations in designing software or choosing a system from the many available options and capabilities? (2) What factors determine whether such systems are likely to be accepted or rejected? (3) What are the likely impacts of such systems upon the individuals, groups, and organizations which use them? It is not the economic costs and benefits, but the social problems and ""payoffs"" in the form of enhanced performance and organizational efficiency that should be the main considerations in deciding whether or not to use a computer-mediated communication system. (4) Given the conditional nature of many of the possible impacts, no system should be implemented without formal evaluation and feedback from users to guide the implementation. The major kinds of evaluational strategies that have been successfully employed are described in this book.
Highly Commended in the category of Oncology at the British Medical Association Awards 2019 The accessible guide to the principles behind new, more targeted drug treatments for cancer Written for anyone who encounters cancer patients, cancer data or cancer terminology, but have no more than a passing knowledge of cell biology. A Beginner's Guide to Targeted Cancer Treatments provides an understanding of how cancer works and the many new treatments available. Using over 100 original illustrations, this accessible handbook covers the biology and mechanisms behind a huge range of targeted drug treatments, including many new immunotherapies. Dr Vickers translates a complex and often overwhelming topic into something digestible and easily understood. She also explains what cancer is, how it behaves and how our understanding of cancer has changed in recent years. Each chapter takes the reader through how new cancer drugs work and their benefits and limitations. With the help of this book, readers will be able to better understand more complex, in-depth articles in journals and books and develop their knowledge. This vital resource: Offers the latest insights into cancer biology Provides a broad understanding of how targeted cancer treatments work Describes many of the new immunotherapy approaches to cancer treatment, such as checkpoint inhibitors and CAR-modified T cells Helps readers feel confident discussing treatment options with colleagues and patients Provides an overview of which treatments are relevant to each of the most common solid tumours and haematological cancers, and the rationale behind them Demystifies the jargon – terms such as the EMT, cancer stem cells, monoclonal antibodies, kinase inhibitors, angiogenesis inhibitors etc. Explains the resistance mechanisms to many new treatments, including issues such as the way cancer cells diversify and evolve and the complex environment in which they live
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.